25.4.2022 17:00:03 CEST | Demant A/S |
Antal stemmerettigheder og kapital
Selskabsmeddelelse nr. 2022-08
25. april 2022
Gennemførelse af kapitalnedsættelse i Demant A/S
Som oplyst i selskabsmeddelelse nr. 2022-07 blev det på Demant A/S’ ordinære generalforsamling den 10. marts 2022 besluttet at nedsætte selskabets aktiekapital med nominelt DKK 1.949.819,60 fordelt på 9.749.098 aktier a DKK 0,20 svarende til selskabets beholdning af egne aktier pr. 27. januar 2022 fraregnet aktier til dækning af ledelsens fastholdelsesprogram og medarbejdernes aktielønsordning.
Offentliggørelse af kapitalnedsættelsen har fundet sted i Erhvervsstyrelsens it-system den 25. marts 2022. Proklamafristen er udløbet uden indsigelser. Kapitalnedsættelsen er derfor anmeldt endeligt til Erhvervsstyrelsen. Efter kapitalnedsættelsen udgør aktiekapitalen i Demant A/S nominelt DKK 46.075.747,00.
I henhold til § 32 i lov om kapitalmarkeder oplyses det hermed, at selskabets samlede aktiekapital og samlede antal stemmerettigheder er opgjort til:
Aktiekapital (nominelt): DKK 46.075.747,00
Antal stemmerettigheder: 230.378.735
Yderligere information:
Søren Nielsen, koncernchef of adm. direktør
Telefon +45 3917 7300
www.demant.com
Øvrige kontaktpersoner:
René Schneider, CFO
Mathias Holten Møller, Head of Investor Relations
Peter Pudselykke, Investor Relations Officer
Trine Kromann-Mikkelsen, VP Corporate Communications and Relations
Om Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Vedhæftninger
2022-08 Gennemførelse af kapitalnedsættelse.pdf
25.4.2022 17:00:03 CEST | Demant A/S |
Total number of voting rights and capital
Company announcement no 2022-08
25 April 2022
Completion of capital reduction in Demant A/S
As stated in company announcement no. 2022-07, it was decided at Demant A/S’ ordinary general meeting on 10 March 2022 to reduce the company’s share capital by nominally DKK 1,949,819.60 divided into 9,749,098 shares of DKK 0.20, corresponding to the company’s holding of treasury shares at 27 January 2022 less shares to cover Management’s retention programme and the share salary arrangement offered to employees.
The capital reduction was published via the electronic information system of the Danish Business Authority on 25 March 2022. The advertisement period expired without any objections being raised. Consequently, we have notified the Danish Business Authority of the capital reduction. After the capital reduction, the share capital of Demant A/S amounts to nominally DKK 46,075,747.00.
In accordance with section 32 of the Danish Capital Markets Act, we hereby state that the company’s total share capital and total number of voting rights amount to:
Share capital (nominal): DKK 46,075,747.00
Number of voting rights: 230,378,735
Further information:
Søren Nielsen, President & CEO
Phone +45 3917 7300
www.demant.com
Other contacts:
René Schneider, CFO
Mathias Holten Møller, Head of Investor Relations
Peter Pudselykke, Investor Relations Officer
Trine Kromann-Mikkelsen, VP Corporate Communications and Relations
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
2022-08 Completion of capital reduction.pdf
